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Abstract
Hantavirus pulmonary syndrome (HPS), also referred to as hantavirus cardiopulmonary syndrome (HCPS), is a rare but
frequently fatal disease caused by New World hantaviruses. In humans HPS is associated with severe pulmonary edema and
cardiogenic shock; however, the pathogenesis of this disease remains unclear largely due to a lack of suitable animal models
for the study of disease progression. In this study we monitored clinical, virological, pathophysiological parameters and host
immunological responses to decipher pathological factors and events in the lethal Syrian hamster model of HPS following
intranasal inoculation of Andes virus. Transcriptional profiling of the host gene responses demonstrated a suppression of
innate immune responses in most organs analyzed during the early stage of infection, except for in the lung which had low
level activation of several pro-inflammatory genes. During this phase Andes virus established a systemic infection in hamsters,
with viral antigen readily detectable in the endothelium of the majority of tissues analyzed by 7–8 days post-inoculation.
Despite wide-spread infection, histological analysis confirmed pathological abnormalities were almost exclusively found in the
lungs. Immediately preceding clinical signs of disease, intense activation of pro-inflammatory and Th1/Th2 responses were
observed in the lungs as well as the heart, but not in peripheral organs, suggesting that localized immune-modulations by
infection is paramount to pathogenesis. Throughout the course of infection a strong suppression of regulatory T-cell
responses was noted and is hypothesized to be the basis of the aberrant immune activations. The unique and comprehensive
monitoring of host immune responses to hantavirus infection increases our understanding of the immuno-pathogenesis of
HPS and will facilitate the development of treatment strategies targeting deleterious host immunological responses.
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Introduction
Hantaviruses (family Bunyaviridae;g e n u shantavirus) are enveloped
viruses which contain a tri-segmented, single-stranded, negative sense
RNA genome encoding four proteins; the nucleoprotein, two
glycoproteins(GNand GC) and an RNA dependant RNA polymerase
[1]. Currently, at least 22 hantavirus species have been described
w o r ld w i d e ,h a lfo fw h ic ha rep a t h o g e n i ct oh u ma n s[ 2 ] .He mo rr h a g i c
fever with renal syndrome (HFRS) is responsible for greater than
200,000 cases annuallyacrossEurope and Asia, and is associated with
mortality rates of up to 10% [3]. The more recently described
hantavirus pulmonary syndrome (HPS) or hantavirus cardiopulmo-
nary syndrome (HCPS) (here referred to as HPS) has a lower
incidence of infection when compared to HFRS, however mortality
rates range from 40–50% [3]. Cases of HPS have been diagnosed
throughout the America’s and are most commonly associated with
infection of either Sin Nombre or Andes viruses (SNV and ANDV,
respectively) [3,4].
Clinically, HPS is defined as a febrile illness distinguished by
diffuse, bilateral interstitial pulmonary infiltrates and compromised
respiratory function which requires supplemental oxygen [5]. In
humans, HPS is characterized by four phases of disease; febrile,
cardiopulmonary, diuretic and convalescent [6]. The initial
symptoms associated with the febrile phase are typically non-specific
(i.e., fever, headache, general malaise and myalgia), however during
the cardiopulmonary phase, HPS rapidly progresses from coughing
and shortness of breath to shock and severe pulmonary edema
requiring intubation and mechanical ventilation. The cardiopulmo-
nary phase is the hallmark of HPS and is characterized by vascular
leakage, which occurs primarily in the lungs, hypoxemia, and
cardiac complications. Death can occur within 48 hours and in
addition to respiratory failure, is due to shock and myocardial
dysfunction. Patients who proceed to the diuretic phase rapidly
improve, though the convalescent phase can last for months [6].
The pathogenesis of HPS remains unclear but likely involves a
versatile balance of viral replication and immune modulation
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are capable of modulating the host cell immune response
accomplishing both immune evasion in early stages of infection
and immune activation later on [7–10]. These findings are
supported by clinical findings of elevated pro- and anti-
inflammatory Th1/Th2 cytokine responses detected in serum
from HPS cases [11] and an increase in cytokine producing cells in
lung sections prepared from fatal HPS cases [12]. In addition,
unique excessive, hantavirus-specific T-cell responses have been
documented in laboratory confirmed HPS cases and are positively
correlated with disease severity [13]. Thus, an underlying immune
dysregulation seems to play an important role in HPS disease
progression, a hypothesis that has been difficult to prove in vivo
without proper animal models.
Currently, only two disease models for hantaviruses have been
described; infection of cynomolgus macaques (Macaca fascicularis)
with wild-type Puumala virus, which mimics a mild form of HFRS
known as nephropathia epidemica [14–16] and infection of Syrian
hamsters (Mesocricetus auratus) with ANDV which results in a
reproducible, lethal outcome with clinical signs similar to HPS in
humans [17–19]. Interestingly, hantavirus infection in Syrian
hamsters is not uniformly lethal. Aside from ANDV, only Maporal
virus, a Venezuelan hantavirus not known to be pathogenic to
humans, has been shown to cause HPS-like disease in hamsters,
albeit with significantly reduced lethality [20]. Other etiological
agents of HPS in humans, including SNV [19] and Choclo virus
[21], are highly infectious but non-pathogenic in hamsters despite
productive infection in endothelial cells of the lung microvascu-
lature.
Here we examined HPS disease progression in Syrian hamsters
following intranasal inoculation of a lethal dose of ANDV. In the
present study we show that ANDV down regulates the host innate
immune response early during infection allowing systemic spread
of the virus. In addition, we found that immediately preceding
clinical onset of disease, activation of innate and Th1/Th2
responses were observed, primarily in lung and heart, while T-
regulatory cell responses were largely absent. Our results indicate
that tissue specific ANDV immune-modulation is a key factor in
HPS pathogenesis.
Results
Infection and disease progression
Inoculation of hamsters with 200 FFU of ANDV via the
intranasal route resulted in 100% lethality occurring between 10
and 13 days post infection (p.i.). Following challenge, hamsters
appeared normal with no obvious signs of adverse effects caused
by the inoculation procedures. Overt signs of disease were not
apparent in any animals until day 9 p.i., with individual hamsters
succumbing to infection approximately 12–36 hours post onset of
clinical signs. The majority of terminally ill hamsters presented
with lethargy, hunched posture and dyspnea, while some also
showed cyanosis and/or epistaxis.
Radiographic imaging was utilized to assess respiratory disease
progression at regular intervals during the course of infection in a
subset of 5 animals, as well as at the time of necropsy for all
hamsters. Changes were first observed between days 7–9 p.i. with
a minority of hamsters showing mild lung infiltration. After day 9
p.i., notable increases in opacity were observed throughout the
lungs of most infected animals. At the time of clinical disease onset
(days 9–11 p.i.), moderate to severe pleural effusions with diffuse
pulmonary infiltrates were visible, followed by rapid pulmonary
consolidation with the most drastic changes observed within the
last 48 hours preceding death (Figure 1). Corroborating the
radiographic observations, increases in the lung weight to body
weight ratios were noted in infected animals, as compared to
control (mock-infected) hamsters, especially after day 9 p.i.
(Figure 2). An average of 3–5 mL of pleural fluid was excised
from a subset of terminally ill hamsters.
Virus detection
Total RNA was extracted from tissue samples and tested for the
presence of ANDV RNA as previously described [22]. ANDV
RNA was detected in the lung of infected animals, as early as
24 hours p.i.. Between days 5–7 p.i., all tissues collected from
infected animals tested positive for ANDV RNA, with peak titers
detected in lung and heart from terminally ill hamsters (Figure 3A).
Viral RNA was first noted in the blood of infected animals on day
7 p.i. and viremia remained relatively low with genome
equivalents ,10ˆ4 (Figure 3A). Infectious viral titers were
determined in a subset of lung samples from infected hamsters
and confirmed the qRT-PCR results (Figure 3B). At no time was
ANDV specific RNA detected in tissues and blood from control
hamsters.
Immunohistochemistry (IHC) was accomplished using a
monoclonal antibody generated against the ANDV nucleoprotein.
Viral antigen was first observed at day 7 p.i. in multiple organs and
cell types including, the lung vascular endothelium and alveolar
septal lining cells (Figure 4), the endothelium of kidney (glomeruli
and intertubular capillaries), trachea and heart (predominantly
myocardial endothelium and, rarely, endocardial endothelium) as
well as multifocal staining in the liver in hepatocytes and sinusoidal
lining cells (most likely Kupffer cells and endothelial cells). In the
spleen, antigen-positive cells were noted primarily in the red pulp
and occasionally in cells with macrophage morphology, and the
cervical lymph nodes, primarily in lymphoid follicles and
endothelial cells. Representative sections of liver, kidney, spleen,
heart and lymph node from a terminally ill hamster are shown in
Figure 5. Similar patterns of antigen staining were observed in
Author Summary
New World hantaviruses, including Andes virus (ANDV), are
rodent-borne pathogens which are associated with
hantavirus pulmonary syndrome (HPS) and case fatality
rates up to 50%. The pathogenesis of HPS remains unclear;
however, it is believed to involve a delicate balance of
virus infection and deleterious immune-modulations. In
this study, exploiting pathological and immunological
approaches, we investigate the disease mechanisms of
HPS caused by ANDV in the lethal Syrian hamster model.
Despite systemic viral replication, pathological findings
were almost exclusively observed in the lungs of infected
hamsters. The most striking observations came from
monitoring the host responses in infected and control
hamsters. During early infection, innate responses in
infected hamsters were down-regulated in all organs
except lung, which demonstrated slight increases in pro-
inflammatory transcripts. Immediately preceding the
symptomatic phase, considerable increases in pro-inflam-
matory and T-cell activating cytokine responses were
observed in lung and heart tissue, but not in other organs.
Interestingly, expression of regulatory T-cell marker genes
that might control deleterious inflammatory responses
were suppressed throughout infection, suggesting a role
in the immune-dysregulation during hantavirus infection.
The results of this study provide an increased understand-
ing of HPS pathogenesis and will aid in the development
of novel therapeutic strategies to counter HPS.
Andes Virus Modulation of Host Immune Responses
PLoS Pathogens | www.plospathogens.org 2 December 2011 | Volume 7 | Issue 12 | e1002426Figure 1. Radiographic imaging and gross lung pathology associated with HPS in hamsters. Hamsters were infected with 200 FFU of
Andes virus as outlined in the materials and methods section. Beginning at 12 hours post-infection and continuing every 1–2 days, infected hamsters
were euthanized and necropsied. Macroscopic evidence of pulmonary damage was first noted at day 7 post-infection (see arrows) with the frequency
and severity of lesions increasing until the terminal phase of disease. Radiographic imaging (X-ray) demonstrated a progression of lung infiltrations
beginning between days 7 and 9 post-infection. Shown are ventral dorsal chest radiographs and gross pathology from a representative hamster
collected at the indicated time points.
doi:10.1371/journal.ppat.1002426.g001
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staining increased in all sections, especially in lungs. Within the
nasal cavity, antigen was detected in the endothelium and in
olfactory epithelial cells after day 9 p.i. (Figure 6). During the
terminal stages of disease (days 10–12 p.i.) there was consistent,
strongly positive antigen staining in pulmonary alveolar septal cells
and occasionally alveolar luminal cells most likely alveolar
macrophages. There was no antigen staining in any tissues
examined from control (uninfected) animals.
Pathology and histopathology of ANDV infection
Gross pathological abnormalities were consistently noted in the
lungs of infected animals. Beginning at day 7 p.i., macroscopic
lesions were observed in the lungs of 3 of 6 infected animals. The
frequency and severity of the affected areas increased until the
terminal stage of disease at which point lesions covered $80% of
all lung lobes and were hemorrhagic in appearance (Figure 1).
Macroscopic evaluation of other tissues (trachea, liver, spleen,
heart, kidney, digestive tract and cervical lymph nodes) was largely
unremarkable with the exception of moderate hemorrhages noted
in the cervical lymph nodes of approximately 50% of hamsters
necropsied on days 11 and 12 p.i..
Similar to the gross pathology observed at necropsy, micro-
scopic abnormalities were predominantly observed in the lungs of
infected hamsters and consisted of interstitial pneumonitis and
perivascular pulmonary inflammation with increased numbers of
macrophages and neutrophils, expanding interstitial spaces,
alveolar and perivascular edema, hemorrhage and fibrin deposi-
tion (Figure 4). The severity of lung pathology was rated as mild
(severity scores 1–2) in specimens collected at 12 hours through
day 5 p.i., with only minimally increased neutrophils and
macrophages noted within alveolar septae and small foci within
alveoli and bronchials. Between days 7 through 9 p.i., lung
pathology was rates as mild to moderate (severity scores 2–3) with
notable increases in macrophages and to a lesser extent
neutrophils observed expanding the interstitial spaces. Lung
specimens collected from days 10 and 11 were rated as moderate
to severe (severity scores 3–4), and those from day 12 severe
(severity score 4) with interstitial inflammation characterized by
accumulations of macrophages, lymphocytes, edema, fibrin and
hemorrhage. A definition of scoring parameters can be found in
the materials and methods section. Throughout the study,
histological changes in all lung lobes from individual infected
animals sampled at all time points were consistent and uniform.
At no time point were any histological abnormalities observed in
the heart, spleen, kidney (Figure 5), nasal tract (Figure 6), trachea,
stomach or gastrointestinal tract (data not shown). Mild lympho-
cyte follicular and plasma cell hyperplasia were frequently noted in
lymph nodes along with minimally increased neutrophils and
eosinophils and interpreted as reactive lymph nodes and
nonspecific changes (Figure 5). Histologic changes in the liver
were infrequent and unremarkable until the terminal stages of
infection (days 10–12 p.i.) with hepatocyte apoptosis and minimal
lymphohistiocytic inflammation observed in a minority of animals
(Figure 5). Minimal infiltrates of lymphocytes and macrophages in
the meninges and surrounding blood vessels in the parenchyma
(encephalitis) as well as mild hemorrhage were occasionally noted
in the olfactory bulbs of the brain at days 10–12 p.i..
Hematology, coagulopathy and blood clinical
chemistries
Pronounced leukocytosis, mainly consisting of neutrophilia and
lymphocytosis, was observed in infected hamsters as early as day 3
p.i. and continuing throughout the terminal stages of disease (data
not shown). Clinical chemistries were mostly unremarkable in
infected hamsters and differences in platelet counts were not
observed. A slight (average of 5%) increase in hematocrit was
documented, though only at days 11–12 p.i.. Examination of
coagulation parameters (aPTT, PT, TT, Protein S, Protein C and
fibrinogen concentrations) demonstrated a moderate increase in
PT and aPTT and decrease in plasma fibrinogen levels which
corresponded to the clinical phase of disease in hamsters (Table 1).
Protein S activity fluctuated throughout the course of infection,
with decreased activity noted beginning at day 3 p.i.. The
remaining parameters showed minimal or no changes in infected
hamsters as compared to the controls.
Host responses to infection
Host responses (including IL- 1b, 2, 4, 6, 10, 12p35 and 21,
TNF a, IFN c, TGF b, STAT1 and 2, IRF1 and 2, Mx2 and
FoxP3) were monitored in lung, heart, spleen, cervical lymph
nodes and blood samples from infected hamsters and compared to
levels of control animals using recently developed, hamster specific
real-time qRT-PCR assays (Figure 7, Figure S1) [23]. During the
early stages of infection, no induction of the innate immune
responses was observed in most tissues analyzed. The exception to
this was slight increases in pro-inflammatory cytokine transcripts
(IL-1b, IL-6, TNF a, IL-12p35, IFN c and IL-21) in lung samples
from infected hamsters. Beginning at day 7 p.i., transcripts
Figure 2. Lung weight to body weight ratios. Whole lungs were
removed from Andes virus infected hamsters at indicated time points
post-infection and lung to body weight ratios were determined.
Individual dots represent data from a single hamster (expressed as a %)
and are color coded to reflect the signs of infection/disease (as
determined by clinical presentation and gross pathology of lungs, see
inset for legend) of the specific animal. The blue dashed line represents
the average lung to body weight ratio of control (uninfected) hamsters
(n=13) and the red dashed line represents the average ratios of
infected hamsters at the indicated time point. Error bars represent the
standard error of the mean. * Time point p,0.05; ** Time point p,0.01
(infected hamsters compared to controls).
doi:10.1371/journal.ppat.1002426.g002
Andes Virus Modulation of Host Immune Responses
PLoS Pathogens | www.plospathogens.org 4 December 2011 | Volume 7 | Issue 12 | e1002426Figure 3. Andes virus organ titers. ANDV RNA was quantified in organs collected from infected hamsters at the indicated time points using
primers and probe designed against the nucleoprotein coding region (A). Heart samples were not available for analysis at the day 10 time point due
to insufficient levels of RNA. Error bars represent the standard error of the mean. LN, lymph nodes. Infectious ANDV titers were determined in lung
samples from infected hamsters at the indicated time points using a focus-forming unit assay (B). Error bars represent the standard error of the mean.
doi:10.1371/journal.ppat.1002426.g003
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most notable in lung, heart and blood. Following a similar pattern,
activation of Th1 pro-inflammatory and Th2 anti-inflammatory
transcriptional markers was observed in the heart with increased
activation also observed in lung samples (compared to earlier time
points). Most notable were IFN c and IL-10 in both organs and
TNF a and IL-6 in heart and lung, respectively. In comparison to
most host responses monitored throughout the course of infection,
expression of T-regulatory (Treg) cell marker genes (FoxP3 and
TGF b) were relatively static or down regulated as shown in the
lungs, with the exception of transient increases in heart and blood
at days 7–9 corresponding to peak IL-21 expression in the heart.
Due to our small sampling size and the variability associated
with differing responses to infection in outbred animals, a
thorough statistical analysis of the temporal changes in cytokine
transcripts within and between organs could not be accomplished.
However, analyzing patterns of prolonged activation (i.e., $2
consecutive time points) revealed a significant amount of pro-
inflammatory transcripts up-regulated in lungs during early
infection (between days 1 and 7 p.i.), when compared to other
organs examined (6 of 7 in lung, 0 of 7 for cervical lymph nodes
and spleen each, p=0.0210). At later time points, this trend
continued in lung samples with 5 of 7 pro-inflammatory markers
up-regulated compared 1 and 0 in spleen and lymph nodes
respectively. Interestingly, during later disease (between days 7 and
12) a significant increase in the number of activated pro-
inflammatory markers was observed in the heart when compared
to lymph nodes and spleen (7 of 7 versus 0 and 1 respectively,
p,0.01).
Host responses were also monitored in plasma samples from a
subset of infected and control hamsters using a multiplex antigen
capture-based assay as previously described [24]. In general,
hamster cytokines could not be accurately quantified by the anti-
mouse/rat cytokine-specific antibodies utilized in the 58-plex
rodent assay, presumably due to lack of cross-reactivity, as
demonstrated by values far below the least detectable dose and
outside the range of the standard curve. However hamster
chemokines, including IFN c induced protein 10 (IP-10),
Figure 4. Histological examination of lungs from Andes infected hamsters. Hamsters were infected with 200 FFU of ANDV as outlined in
the materials and methods section. Beginning at 12 hours post-infection and continuing every 1–2 days, infected hamsters were euthanized and
necropsied. Shown are representative sections of lungs stained with hematoxylin and eosin (H&E, 200X magnification) or a monoclonal antibody
targeting the ANDV nucleoprotein (IHC, 400X magnification) from a representative hamster collected at the indicated time points. Histological
changes were first apparent at day 7 post-infection and included increased immune cell (predominantly macrophages, neutrophils and lymphocytes)
infiltration (circled areas), hemorrhage (closed arrow heads), fibrin deposition (F) and edema (e). Diffuse staining of lung endothelium and alveolar
septal cells (arrows) was also apparent beginning at 7 days post-infection. Note, samples shown correspond to the same hamsters in Figure 1.
doi:10.1371/journal.ppat.1002426.g004
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PLoS Pathogens | www.plospathogens.org 6 December 2011 | Volume 7 | Issue 12 | e1002426Figure 5. Histological analysis of peripheral organs from Andes virus infected hamsters. Representative samples of heart, kidney, liver,
lymph nodes and spleen sections collected at day 12 post-infection from a terminally ill, ANDV infected hamster are shown (H&E 200X, anti-Andes
virus nucleoprotein IHC 400X). Extensive viral antigen was noted in endothelial cells of all tissues analyzed (black arrow), including endocardial
endothelium in heart sections (open arrow) and glomerular tuft endothelium in kidney sections (circled areas) as well as hepatocytes and Kupffer cells
in liver sections (denoted with an H and K, respectively) and dendritic cells and macrophages in lymph nodes (circled area). Despite the high
frequency of antigen positivity in peripheral tissue samples, histological abnormalities were infrequent and largely unremarkable in these organs.
doi:10.1371/journal.ppat.1002426.g005
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chemoattractant protein 1(MCP-1), were quantifiable with this
assay (i.e., provided measurable values within the dynamic range
of the assay) and demonstrated increased levels of detection
throughout the course of infection (Figure 8). Other plasma
factors, including vascular cell adhesion molecule 1(VCAM-1), von
Willebrand factor (vWF), vascular endothelial cell growth factor
(VEGF), macrophage-derived chemokine (MDC), stem cell factor
(SCF), showed similar cross-reaction and demonstrated relative
increases (VCAM-1) or no change (vWF, VEGF, MDC, SCF,
Figure 8, data not shown), during the course of infection. Further
validating these results, IHC performed with a polyclonal antibody
specific for VEGF demonstrated no discernable differences in
VEGF expression in lung samples collected from infected or
control hamsters (data not shown).
Discussion
The pathogenesis of HPS has basically evolved from studying a
limited number of surviving and lethal HPS cases [6,25,26].
Efforts at modeling HPS disease in animals have largely failed,
with the exception of the lethal ANDV model in Syrian hamsters
[17]. The use of the hamster model has been hampered by the lack
of species-specific reagents and therefore mainly focused on
virology and histopathology [17–19]. Recently we have developed
tools to follow certain hamster-specific immune responses upon
stimulation at transcriptional level [23], which allowed us to
perform a unique and comprehensive evaluation of the host
immune responses in hamsters following intranasal ANDV
infection, a route that mimics natural exposure of humans to
hantaviruses.
ANDV pathogenesis following intranasal infection of
hamsters
Intranasal ANDV inoculation established a systemic infection in
hamsters with viral specific RNA detectable in blood and all tissues
analyzed from day 7 p.i. on (Figure 3A). The lung was the only
organ that showed consistent virus replication starting at day 1 p.i.
Despite systemic infection, histological changes were consistently
observed only in the lungs of infected animals including
pulmonary interstitial inflammation, edema, fibrin deposition
and hemorrhages (Figures 1 and 4). Histological changes in other
organs (heart, kidney, liver, cervical lymph nodes, spleen and
trachea) were infrequent, minor, and only apparent in samples
from terminal animals, making their contribution to disease
development less likely. The lung, therefore is the predominant
affected organ during infection and responsible for the clinical
disease manifestation. However, mild to moderate subacute
hepatitis and hepatocellular necrosis have been described in
hamsters intramuscularly or intraperitoneally infected with ANDV
[17, 19; own unpublished data] suggesting differences in disease
development depending on the route of infection.
Previously, it has been reported that ANDV is capable of
establishing a productive infection in primary respiratory epithelial
cell cultures [27]. Here we assessed the role of the upper
respiratory tract tissues for hantavirus replication following
intranasal inoculation. Interestingly, sections of the nasal cavity
were uniformly ANDV antigen negative until day 9 p.i., after
which focal, patchy antigen staining of the epithelial cell lining,
most notably in the olfactory epithelial cells, was observed in the
absence of any discernable viral induced cellular damage
(Figure 6). Despite an increase in antigen staining intensity of
single infected cells over time, spread to surrounding epithelial
cells was rare. This is in contrast to virus spread in the
endothelium of other organs such as lung, kidney, heart and liver.
These results suggest that epithelial cells of the upper respiratory
tract are capable of supporting ANDV replication but are unlikely
to play an important role in virus dissemination. However, we
Figure 6. Histological analysis of the upper respiratory tract of
Andes virus infected hamsters. At the conclusion of each necropsy,
hamsters were decapitated and the head was skinned, fixed in 10%
neutral buffered formalin, decalcified and sectioned for histological
analysis of the upper respiratory tract. Throughout the course of the
study no discernable virus induced pathology was noted in the upper
respiratory tract of infected hamsters. (A, 40X magnification of upper
respiratory tract of infected hamsters collected at day 10 post-infection).
Immunohistochemistry demonstrates the presence of ANDV infected
olfactory epithelial cells (black arrow) and endothelium (open arrow) in
the upper respiratory tract of hamsters at days 10 (B, 200X
magnification) and 12 (C, 400X magnification) p.i.
doi:10.1371/journal.ppat.1002426.g006
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contribute to host to host transmission, a phenomenon that has
only been described for ANDV infections in humans [28,29].
The earliest signs of infection were manifest in hematology with
pronounced increases of neutrophils and lymphocytes beginning at
day 3 p.i. and continuing throughout the course of infection.
Similar hematological changes have been described in HPS cases
[30]. Examination of coagulation parameters indicated coagula-
tion abnormalities with a weak tendency for hemorrhages. The
most prominent observations were prolonged aPTT values and
decreased plasma fibrinogen concentrations during the symptom-
atic phase (Table 1). Decreases in fibrinogen concentrations are
associated with impairment of primary and secondary hemostasis,
which results in increased clotting times as observed here. Similar
findings have also been noted in Chilean HPS cases [30].
Interestingly, hemorrhagic manifestations were uniquely observed
in South American HPS cases suggesting that ANDV possesses the
potential to cause hemorrhages as supported by epistaxis in
terminal ANDV infected hamsters.
Recently it was shown that ANDV infection of primary lung
endothelial cells resulted in upregulation of VEGF and downreg-
ulation of vascular endothelial (VE)-cadherin, both of which are
associated with increased vascular permeability [31]. While we
were unable to monitor VE-cadherin, no differences in expression
of VEGF in infected or control lungs were observed by IHC (data
not shown) and plasma concentrations of VEGF did not differ
between infected and control hamsters (Figure 8).
ANDV down-regulates innate immune responses in
hamsters early in infection
As known from other virulent RNA virus infections [32,33],
modulating the host cell immune response seems to be key for
establishing hantavirus infections. In vitro studies have demonstrat-
ed that human pathogenic hantaviruses down regulate the innate
immune response early after infection [8,9]. Similarly, a recent
study by Stoltz and colleagues demonstrated decreased serum
concentrations of IFN-lambda in patients infected with hantavi-
ruses, providing evidence of down regulation of innate responses in
vivo [34]. In our study, a global suppression of innate immune-
related responses, particularly for the type I interferon responses,
was observed early after infection until about day 7 p.i. (Figure 7).
The exception to this was low-level induction of pro-inflammatory
responses in the lung. Subsequent up-regulation of innate immune
responses correlated with both viremia and the appearance of viral
antigen in the majority of organs. Despite continuing up-
regulation of these responses ANDV continued to replicate, as
demonstrated by increasing intensities of IHC staining and
increasing RNA titers suggesting that following day 7 p.i., the
immune response is overwhelmed and no longer capable of
controlling ANDV replication.
ANDV causes downregulation of Treg cell markers in
hamsters
It is well established that downregulation of Treg cells results in
disrupted immune homeostasis leading to immunopathology,
while a vigorous Treg response can result in viral persistence
[35,36]. Recent studies have suggested an important role of Treg
cells for hantavirus persistence in rodents [37–39] and disease
development in HPS [11] and HFRS [40] patients. Schountz and
colleagues demonstrated that deer mice persistently infected with
SNV have a robust TGF b response and they speculated that Treg
cells play an important role in limiting the immunopathology in
infected deer mice [37]. Similar results have been documented in
rats persistently infected with Seoul virus, an Old World
hantavirus associated with HFRS in humans [38]. Conversely,
decreased levels of TGF b associated with increased pro-
inflammatory responses have been documented in HPS patients,
supporting a deficient Treg response as a key factor in HPS
immunopathogenesis [11]. Throughout the course of ANDV
infection in hamsters, relatively static or decreased transcription
levels of TGF b and FoxP3 were observed (Figure 7, Figure S1),
supporting that ANDV is capable of modulating Treg cell
responses likely contributing to immunopathogenesis of HPS.
Although the target organ of HFRS differs from HPS, a recent
study demonstrated that Treg responses in HFRS patients were
negatively correlated with disease severity, suggesting a similar
mechanism of pathogenesis [40].
Organ-specific host responses to HPS
Pathology was focused in the lungs of ANDV infected hamsters
which correlates well with the early and eventually strong immune
response to infection in the lung and the primarily respiratory
disease manifestation. Other organs are clearly infected, with
Table 1. Summary of coagulation parameters monitored in control and Andes infected hamsters.




time (s, ±SEM) Protein C* (%) Protein S* (%)
Control 21.0760.44 10.8060.45 313.11612.14 30.4761.02 100 100
Day 1 20.0560.99 9.7560.15 347.13622.74 26.6560.68 100 100
Day 3 21.1360.57 9.5360.55 320.14629.80 25.0861.25 100 61.1
Day 5 21.5560.20 9.4360.44 265.20637.56 27.9261.26 92 74.4
Day 7 22.6560.42 10.6260.14 333.32618.13 28.5361.09 100 81.1
Day 8 22.0261.18 11.5060.18 324.52610.88 26.4261.42 100 91.1
Day 9 23.3561.10 10.0160.14 333.82613.04 29.3761.28 100 86.1
Day 10 24.9861.53 12.1461.36 290.33659.70 32.5763.87 100 91.7
Day 11 29.8461.42* 10.6660.49 262.72646.97 33.5364.73 100 60.6*
Day 12 43.1063.46* 13.7062.07* 148.90647.02* 24.0863.44 96 59.6*
p value ,0.001 0.0234 0.0115 - - 0.0416
*Protein C and Protein S expressed as percent activity compared with control, uninfected hamsters.
doi:10.1371/journal.ppat.1002426.t001
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PLoS Pathogens | www.plospathogens.org 10 December 2011 | Volume 7 | Issue 12 | e1002426evidence for ANDV replication in endothelial cells, but with the
exception of the heart, measurable Th1/Th2 immune responses
could not be detected in these organs (Figures 5 and 7). The
mechanism responsible for the organ-specificity of the immune
responses is unclear, however does not rely exclusively on viral
replication. Supporting this, other HPS-causing hantaviruses have
been shown to replicate in the lung microvasculature of hamsters
without apparent disease manifestations [21]. Cells of the
respiratory system appear to respond differently to ANDV
infection. Interestingly, slight increases in a significant number of
pro-inflammatory cytokine responses were observed in lungs early
in ANDV infection (Figure 7). Early, low level, induction of
inflammatory cytokines may prime the lung for the ensuing
uncontrolled immune responses and subsequent immune-mediat-
ed pathogenesis, without negatively impacting viral replication.
Interestingly, immediately prior to physical signs of disease, a
significant amount of pro-inflammatory cytokine markers were
detected in heart samples, suggesting cardiac activation occurs
later in disease and may provide the final coup d’e ´tat.
Our present study strongly suggests that HPS can be
categorized as a severe disease induced by organ-specific
pathological changes associated with dysregulation of organ-
specific host responses. Supporting this, a study by Mori and
colleagues demonstrated an increase of cytokine producing lung
cells in HPS cases, but not other organs [12]. Saggioro et al.
described elevated levels of TNF a in the heart of HPS cases [41].
While neither of these studies analyzed both organs, heart and
lung, from individual cases, the results support an organ-specific
host response in HPS cases similar to that described here in
ANDV infected hamsters. While we were unable to monitor
circulating cytokine responses (lack of tools for hamsters), our
results suggest the elevated levels of plasma cytokines observed in
HPS cases originate from activated lymphocytes, endothelial cells
and/or macrophages from lungs and heart.
The role of TNF a in the pathogenesis of HPS and particularly
for increased vascular permeability is controversial [42,43]. Our
study showed weak to moderate levels of TNF a in lung and heart
of ANDV infected animals. Saggioro et al. detected elevated levels
TNF a in heart tissue from HPS cases [41] and suggested its role
in myocardial depression and shock. Signs of cardiogenic shock
have also been reported in the terminal stages of HPS disease in
hamsters [18]. While we were unable to monitor cardiogenic
shock, increased cytokine levels in heart and lungs from infected
hamsters (Figure 7, Figure S1) and humans [11,41] including
elevated levels of TNF a and IL-6, which both suppress
myocardial function [44,45], and IL-12, which has been associated
with myocarditis in mice [46] support cardiac depression in HPS.
Curiously, our findings of increased IL-12 expression in heart
samples suggest a Th1 response yet no evidence of Th1 type
pathology was noted in heart samples, possibly due to a regulatory
effect of IFN c [46]. Despite the lack of apparent viral induced
pathology in heart tissue of ANDV infected hamsters, expression
of certain cytokines with impact on myocardial function support
the role for cardiac involvement in HPS and lends support to the
alternative designation HCPS [3].
Of note is the increased IL-21 expression in heart tissue of
ANDV infected hamsters. IL-21 plays a critical role in the
differentiation of Th17 cells, a newly recognized subset of T cells
with opposite function to Treg cells and involvement in
autoimmune processes [47,48]. Previously, it has been speculated
that an unfavorable imbalance of immuno-regulatory Treg cells
and immuno-pathogenic Th17 cells contribute to pathogenesis of
a diverse group of immune-mediated diseases, including inflam-
matory disease and acute heart failure [48–50], two syndromes
associated with HPS. Thus future studies need to confirm a
potential novel role of impaired Treg responses and Th17
differentiation for the immunopathogenesis of HPS.
The dogma of T cell mediated immunopathogenesis of
hantavirus infections was recently challenged by Hammerbeck
and Hooper [51]. Using the hamster model of HPS, the authors
demonstrated increases in activated T cells in lung and spleen
samples from ANDV infected hamsters which correlated with the
onset of disease and subsequent death. Interestingly, they also
found that HPS disease progression and lethal outcome in
hamsters depleted for CD4+ and/or CD8+ T cells was
indistinguishable from that in undepleted animals, suggesting that
T cells are not critical in HPS disease development [51].
The timing of the increases in activated T cells noted by
Hammerbeck and Hooper in undepleted hamsters appears to
correlate with the onset of the aberrant immune responses
observed in our study (Figure 7) [51]. Interestingly, although
increases in activated T cells were noted in both lung and spleen
[51], in our study the aberrant immune responses were noted in
the lung, but not the spleen of infected animals. While we are
unable to define the cell types responsible for increased cytokine
production, combined with the results of Hammerbeck and
Hooper, it is reasonable to believe that the tissue specific,
abnormal immune response in ANDV infected hamsters is not
exclusively due to T cells. Other cell types, for example
monocytes, dendritic cells or alveolar macrophages, may also
play an important role. However, since T cell depletions were
conducted at 6 to 8 days post-ANDV inoculation [51], the
current data cannot rule out the effects of early activation of T
cells and its effects on potential cross-talk with other cell types
noted above, as well as the pulmonary endothelium. Further-
more, a recent review of the pathogenesis of HPS and HFRS
suggests a more intricate balance of T cell involvement in which
cellular responses that are too aggressive or too weak may
similarly result in severe disease [52]. This may in part explain
the results of the recent depletion study [51]. Nevertheless, the
study by Hammerbeck and Hooper [51] along with our study,
highlight the complexity of HPS pathogenesis and demonstrate
the utility of the hamster model for elucidating mechanisms of
disease development.
Systemic mediators of infection
Attempts to quantify plasma cytokine responses in hamsters
using reagents developed for other rodent species were largely
unproductive. Most likely this is due to a lack of cross-reaction,
which has been shown previously in Pichinde infected hamsters
[24]. Attempts to detect hamster cytokines using rodent specific
ELISA and Luminex panels were also unproductive [23, own
unpublished data]. Despite this, hamster chemokines were
quantifiable with the Rodent-MAP platform and several demon-
strated increased levels during the course of ANDV infection. Of
note were increases in immunoattractant proteins including MCP-
Figure 7. Host responses to Andes virus infection. Host responses to ANDV infection were monitored using recently developed, hamster
specific, real-time RT-PCR assays. The average fold changes in lung, heart, spleen, cervical lymph nodes and blood samples from a minimum of 6
infected animals per time point are shown. Data collected is normalized uninfected animals. Day 10 heart samples were not tested due to insufficient
RNA concentrations following extraction. Spleen samples were not tested for STAT-2 or IRF-2 for the same reason.
doi:10.1371/journal.ppat.1002426.g007
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induced following hantavirus infection in primary endothelial cell
culture [53]. Combined these proteins likely provide the
chemotaxis for immune cell infiltration observed in the lungs.
Although we were unable to quantify hamster cytokines beyond
the transcript level, upregulation of IP-10 and VCAM-1 indirectly
Figure 8. Analysis of plasma concentrations of inflammatory mediators. Plasma samples from control (n=6) and Andes virus infected
(n=22) hamsters were tested for analytes using the RodentMAP version 2.0 platform. Samples from infected hamsters were divided into early (n=6,
collected on day 1 post-infection, p.i.), middle (n=8, collected on days 7–8 p.i.), or late (n=8, collected on days 11–12 p.i.) stages of disease. Shown
are data from biomarkers that sufficiently cross-reactive with the mouse/rat specific assay. IP, inducible protein; M-CSF, macrophage-colony
stimulating factor; MCP, monocyte chemoattractant protein; VCAM, vascular cell adhesion molecule; vWF, von Willebrand factor; VEGF, vascular
endothelial cell growth factor; MDC, macrophage-derived chemokine; SCF, stem cell factor. * p,0.01, ** p,0.001; *** p,0.0001 (indicated time point
to uninfected controls).
doi:10.1371/journal.ppat.1002426.g008
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cytokines including IFN c and TNF a.
Model of HPS pathogenesis in Syrian hamsters
In conclusion, following intranasal infection, a broad suppres-
sion of innate responses allows ANDV to establish an infection in
the lower respiratory tract with subsequent systemic spread.
Early measurable signs of infection are hematological abnor-
malities and pulmonary infiltration, primarily consisting of
neutrophils and macrophages early, and macrophages and
lymphocytes later in disease. A crucial time during infection lies
around day 7 p.i., when initial immune suppression switches to
immune activation which appears to be triggered through
continuous suppression of host regulatory responses (i.e., Tregs),
and uncontrolled viral replication. The terminal stage starts with
the appearance of clinical signs around day 9 p.i. when
radiographic changes can be observed. This period is short
and animals succumb to infection within 36–48 hours, as has
been described for human HPS cases. Virus dissemination seems
to occur through viremia but the primary organ for virus
replication and immune-associated damage through host re-
sponses is the lung followed by the heart. Thus, pathogenesis
seems to be a result of a combination of virus replication with an
early suppression of the host innate immune responses followed
by a virus-triggered organ-specific deleterious host immune
response resulting in pulmonary damage and cardiac suppression
leading to respiratory distress.
Materials and Methods
Ethics statement
All animal experiments were approved by the Institutional
Animal Care and Use Committee of the Rocky Mountain
Laboratories (ASP #2009-43), and performed following the
guidelines of the Association for Assessment and Accreditation of
Laboratory Animal Care, International (AAALAC) by certified
staff in an AAALAC approved facility.
Biosafety and containment
All work with infected hamsters and potentially infectious
materials derived from hamsters was conducted in the Biosafety
Level 4 facility at the Rocky Mountain Laboratories, Division of
Intramural Research, National Institute of Allergy and Infectious
Diseases, National Institutes of Health. Sample inactivation and
removal was performed according to standard operating protocols
approved by the local Institutional Biosafety Committee.
Inoculation of hamsters
ANDV, strain Chile 9717869 [54], was propagated and titered
as previously described [22]. Syrian hamsters (female, aged 4–6
weeks) were inoculated with 200 focus forming units (FFU) of
ANDV (1006LD50), a dose previously determined to be uniformly
lethal in this model, diluted in sterile DMEM and administered
through the intranasal route with 50 ml of virus suspension
delivered per nare using a sterile p200 pipette. Control animals
received an equivalent volume of sterile DMEM alone.
Sample collection
At 12 hours and 1, 3, 5, 7, 8, 9, 10, 11 and 12 days p.i., one
control and six infected hamsters were anesthetized via inhala-
tional isoflurane and chest radiographs (ventral dorsal, right and
left lateral) were taken using a portable digital radiography unit
with a flat panel digital detector (TruDR, Sound-Eklin, Carlsbad,
CA) and veterinary specific software (VET-PACS, London,
United Kingdom). Hamsters were weighed, bled (EDTA and
heparin treated 1.8 mL vacutainer tubes) and exsanguinated via
cardiac puncture. Necropsies were performed to collect trachea,
lung, liver, spleen, heart, kidney, digestive tract (stomach and
intestines) and cervical lymph nodes. Lungs were removed,
photographed, weighed, and a representative sample was taken
from each lobe for histopathology (see below). In addition, a piece
of the left lung was processed for RT-PCR as outlined below.
Organ samples were processed for molecular analysis, histopa-
thology and IHC. For molecular analysis, pieces of tissue
(approximately 100 mg) were immersed in 1 mL of RNAlater
(Qiagen, Valencia, CA) for overnight at 4uC, removed and stored
at 280uC until RNA extraction. The remainders of each organ
were fixed in 10% neutral buffered formalin for seven days at 4uC
and processed as outlined below for histopathology and IHC. The
head was skinned and fixed in 10% neutral buffered formalin for
histological analysis of the upper respiratory tract. Lung weight to
body weight ratios were calculated and pairwise comparisons of
data from control and infected hamsters performed at each
interval using t-tests.
Clinical score
Hamsters were assigned a clinical score based on signs of
infection/disease as determined by clinical presentation and gross
pathology of lungs as follows: no signs = indistinguishable from
controls; mild = hamsters appeared lethargic, lesions on single
lung lobes; moderate = onset of breathing abnormalities (rapid
shallow breathes), lesions apparent on multiple lung lobes; severe
= breathing distress, multi-focal lesions of increased size on all
lung lobes; terminal = moribund, epistasis, lungs hemorrhagic in
appearance.
Time-course radiographs
Disease progression was monitored in a subset of five ANDV
infected hamsters with chest radiographs taken at one to two day
intervals until day 7 p.i. and twice daily (approximately 12 hours
apart) from day 7 p.i. until the point of euthanasia.
Hematology and blood chemistry
Blood chemistry was monitored in heparinized blood using a
portable iSTAT instrument (Abbott Point of Care, Princeton, NJ)
with EC8+ cartridges measuring Na, K, Cl, TCO2, anion gap,
glucose, urea nitrogen, hematocrit, hemoglobin, pH, pCO2,p O 2,
TCO2, HCO3, and base excess. Hematology, including white
blood cell count, lymphocyte, platelet, reticulocyte and red blood
cell counts, hematocrit values, mean cell volume, mean corpus-
cular volume, and mean corpuscular hemoglobin concentrations,
was performed on EDTA blood using a Hemavet 950FS (Drew
Scientific, Waterbury, CT).
Coagulation testing
Due to the volume of plasma required for the coagulation
examination, a second group of one control and six infected
hamsters were exsanguinated via cardiac puncture at days 1, 3, 5,
7, 8, 9, 10, 11 and 12 p.i. with blood collected into 1.8 mL citrate
vacutainers. Plasma was tested for coagulation parameters,
including activated partial thromboplastin time (aPTT), pro-
thrombin time (PT), thrombin time (TT), fibrinogen concentra-
tion, and Protein S and Protein C activity, on a STart4 instrument
using the PTT Automate, STA Neoplastine CI plus, STA
Thrombin, Fibri-Prest automate, STA Staclot Protein S and
Protein C kits, respectively (all from Diagnostica Stago, Parsip-
pany, NJ). Data was analyzed using a one-way analysis of variance
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comparing values from infected hamsters to uninfected controls.
Histopathology and IHC
Formalin fixed tissues were processed and embedded in paraffin
according to standard procedures. For sectioning of the nasal tract,
the mandible and any extraneous muscle was removed from
formalin fixed skulls to expose the cranium. Skulls were rinsed in
running tap water, placed in a decalcifying solution consisting of
20% EDTA in sucrose (Newcomer Supply, Middleton WI) and
allowed to sit at room temperature for 3–5 weeks, with 2–3
changes of decalcification solution over that period. Following
decalcification, skulls were processed and embedded in paraffin.
Thin (5 mm) sections were cut and stained with hematoxylin and
eosin or tested for the presence of viral antigen by IHC using a
monoclonal antibody generated against the ANDV nucleoprotein
(1:500 dilution, clone 1A8F6, Austral, San Ramon, CA). IHC was
accomplished on a Discovery XT instrument (Ventana Medical
Systems, Tucson, AZ) using a biotinylated goat anti-mouse (1:250
dilution, BioGenex, San Ramon, CA) secondary antibody and
DAB Map kit. Following immunological staining, slides were
counterstained with hematoxylin, dehydrated, cleared in xylene,
and coverslipped. In addition, lung sections were stained for
vascular endothelial growth factor (VEGF, 1:100 dilution, sc-507,
Santa Cruz Biotechnology, Santa Cruz, CA) using a cross-reactive
polyclonal antibody generated in rabbits essentially as outlined
above with an alkaline phosphatase conjugated secondary
antibody (Ventana Medical Systems).
Slides were evaluated by a Veterinary Pathologist. The scoring
for H and E stained lung specimens were as follows: 1 =
Minimally increased numbers of inflammatory cells within
alveolar septae without widening of the septae; 2 = Mildly
increased numbers of inflammatory cells within septae and mild
expansion, or thickening, of septal walls and occasional extension
of inflammation into the lumen of alveoli and bronchioles; 3 =
Interstitial inflammation (alveolar septae and perivascular, peri-
bronchiolar and peribronchial) and inflammation within alveoli
and larger airways (inflammatory cells, fibrin, hemorrhage).
Inflammation may be extensive and involve large areas of the
tissue section; 4 = Changes are as described for #3; however,
extent of lesions is greater and involves most of the tissue section.
Transcriptional profiling of host response and virus
replication
RNA was extracted from solid tissues (30 mg pieces) and blood
samples using RNeasy or QIAamp viral RNA kits (Qiagen),
respectively, according to manufacturers’ instructions. Immedi-
ately after extraction, RNA was quantified on a nanodrop 8000
spectrophotometer (Thermo Scientific, Wilmington, DE). Sample
concentration was adjusted to 40 ng/ml and aliquots frozen at -
80uC. Real-time quantitative (q) RT-PCR was performed on a
rotor-gene 6000 instrument (Corbett Life Science, Sydney
Australia) using QuantiFast probe reagents (Qiagen) and 200 ng
of template RNA. The presence of ANDV RNA was quantified
using a previously described nucleoprotein specific assay [22].
Host responses, including interleukin (IL) 1b, 2, 4, 6, 10, 12p35,
and 21, tumor necrosis factor alpha (TNF a), interferon gamma
(IFN c), transforming growth factor beta (TGF b), forkhead box
P3 (FoxP3), myxovirus resistance protein 2 (Mx2), interferon
regulatory factor 1 (IRF1) and 2 (IRF2), and signal transducer and
activator of transcription 1 (STAT1) and 2 (STAT2), were
monitored in lung, spleen, heart, cervical lymph node and blood
samples using recently developed Syrian hamster specific, real-
time qRT-PCR assays using ribosomal protein L18 as an internal
control [23]. The small group sizes used in these studies prevented
a thorough statistical analysis of temporal transcriptional data;
however, patterns of up-regulation of pro-inflammatory markers
were analyzed using Chi square tests.
Multiplex cytokine, chemokine, and plasma factor
analysis
Plasma samples from a subset of infected (n=22) and control
(n=6) hamsters were sent to Rules-Based Medicine, Inc (Austin,
TX) for analysis of cytokine and chemokine concentrations using a
58-biomarker Multi-Analyte Profile (MAP) approach (Rodent-
MAP version 2.0). Samples from infected animals were divided
into three categories; early (n=6, collected on day 1 p.i.), middle
(n=8, collected on days 7–8 p.i.), and late (n=8, collected on days
11–12 p.i.) stages of disease. Although this platform has only been
validated against mouse and rat samples, recently it was suggested
to work for selected hamster biomarkers, especially chemokines
[24]. Data was analyzed using a one-way ANOVA with Tukey-
Kramer multiple comparison post-test.
Virus titration
Infectious viral loads were measured in a subset of lung
homogenates (10% [w/v]) from infected hamsters using a focus
forming unit assay essentially as previously described [22].
Accession numbers
GenBank accession numbers are as follows: IL-1b AB028497;
IL-2 EU729351; IL-4 AF046213; IL-6 AB028635; IL-10
AF046210; IL-12p35 AB085791; IL-21 FJ664142; TNF a
AF315292; IFN c AF034482; TGF b AF046214; FoxP3 FJ
664148; Mx2 EU616539; IRF1 DQ092344; IRF2 AY714581;
STAT1 DQ092343; STAT2 AB177399; ribosomal protein L18
DQ403027.
Supporting Information
Figure S1 Host responses to Andes virus infection. Host
responses to Andes virus infection were monitored using recently
developed, hamster specific, real-time RT-PCR assays. Shown is
the qRT-PCR data used to generate the heat maps in Figure 7.
Error bars represent the standard error of the mean.
(TIFF)
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